The Vascular Dementia Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for vascular dementia has experienced significant growth in recent years. The market, which was valued at $2.92 billion in 2024, is expected to increase to $3.27 billion in 2025, signifying a compound annual growth rate (CAGR) of 12.1%.
The Vascular Dementia Global Market Report 2025 forecasts that by 2029, the market size of vascular dementia will reach $5.11 billion, with a compound annual growth rate (CAGR) of 11.8%.
Download Your Free Sample of the 2025 Vascular Dementia Market Report and Uncover Key Trends Now!The key drivers in the vascular dementia market are:
•Increasing awareness of vascular dementia
•Rising healthcare investments
•Growing aging population
•Rising prevalence of cardiovascular diseases and high blood pressure
The vascular dementia market covered in this report is segmented –
1) By Product: Monoclonal Antibodies, Small Molecules, Peptides
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics
Subsegments:
1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies, Anti-Tau Monoclonal Antibodies
2) By Small Molecules: Cholinesterase Inhibitors, Glutamate Modulators, Anti-Inflammatory Small Molecules
3) By Peptides: Amyloid-Beta Targeted Peptides, Neuroprotective Peptides, Tau-Targeting Peptides
The key trends in the vascular dementia market are:
•Technological advancements are becoming a key trend in the vascular dementia market.
•Personalized care plans are beginning to gain popularity.
•The use of telemedicine is trending in vascular dementia treatment.
•Gene therapy and artificial intelligence are emerging as new trends.
Major players in the vascular dementia market are:
• Intermountain Healthcare Inc.
• CSPC Ouyi Pharmaceutical Co. Ltd.
• Duke Health
• Massachusetts General Hospital
• Emory Healthcare Inc.
• Apollo Hospitals Enterprise Limited
• Amedisys Inc.
• Northwestern Memorial HealthCare
• IBS Hospitals Pvt. Ltd.
• Resverlogix Corp.
• ProNeurogen Inc.
• Cyclerion Therapeutics Inc.
• Aribio Inc.
• Pinteon Therapeutics Inc.
• Dementech Neurosciences Ltd.
• Moleac Pte. Ltd.
• Isaac Health Inc.
• Cadabam’s Group of Hospitals
• Alpha Cognition Inc.
• Citi Health
North America was the largest region in the vascular dementia market in 2024